Entity Common Stock, Shares Outstanding of EAGLE PHARMACEUTICALS, INC. from 12 May 2014 to 01 Aug 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
EAGLE PHARMACEUTICALS, INC. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 12 May 2014 to 01 Aug 2023.
  • EAGLE PHARMACEUTICALS, INC. Entity Common Stock, Shares Outstanding for the quarter ending 01 Aug 2023 was 12,986,971, a 2.2% decline year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

EAGLE PHARMACEUTICALS, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2023 12,986,971 -297,588 -2.2% 01 Aug 2023 10-Q/A 09 Aug 2023 2023 Q2
Q1 2023 13,084,243 +385,677 +3% 16 Mar 2023 10-K 23 Mar 2023 2022 FY
Q3 2022 13,015,856 +101,977 +0.79% 02 Nov 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 13,284,559 +187,446 +1.4% 02 Aug 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 12,698,566 -410,801 -3.1% 25 Apr 2022 10-K/A 02 May 2022 2021 FY
Q3 2021 12,913,879 -116,251 -0.89% 02 Nov 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 13,097,113 -509,858 -3.7% 02 Aug 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 13,109,367 -575,751 -4.2% 03 May 2021 10-Q 10 May 2021 2021 Q1
Q3 2020 13,030,130 -641,042 -4.7% 29 Oct 2020 10-Q 02 Nov 2020 2020 Q3
Q2 2020 13,606,971 -59,909 -0.44% 03 Aug 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 13,685,118 -244,352 -1.8% 04 May 2020 10-Q 11 May 2020 2020 Q1
Q3 2019 13,671,172 -1,241,987 -8.3% 31 Oct 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 13,666,880 -1,389,044 -9.2% 31 Jul 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 13,929,470 -905,968 -6.1% 30 Apr 2019 10-Q 07 May 2019 2019 Q1
Q3 2018 14,913,159 -8,464 -0.06% 25 Oct 2018 10-Q 01 Nov 2018 2018 Q3
Q2 2018 15,055,924 -113,317 -0.75% 31 Jul 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 14,835,438 -391,727 -2.6% 03 May 2018 10-Q 10 May 2018 2018 Q1
Q3 2017 14,921,623 -514,105 -3.3% 01 Nov 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 15,169,241 -467,146 -3% 02 Aug 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 15,227,165 -409,222 -2.6% 03 Mar 2017 10-K 15 Mar 2017 2016 FY
Q3 2016 15,435,728 -154,116 -0.99% 04 Nov 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 15,636,387 +46,543 +0.3% 04 Aug 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 15,636,387 +97,444 +0.63% 03 May 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 15,636,387 +1,604,220 +11% 10 Feb 2016 10-K 29 Feb 2016 2015 FY
Q3 2015 15,589,844 10 Nov 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 15,589,844 +1,569,711 +11% 10 Aug 2015 10-Q 11 Aug 2015 2015 Q2
Q1 2015 15,538,943 +1,518,810 +11% 11 May 2015 10-Q 15 May 2015 2015 Q1
Q4 2014 14,032,167 17 Dec 2014 10-K 22 Dec 2014 2014 FY
Q2 2014 14,020,133 08 Aug 2014 10-Q 11 Aug 2014 2014 Q3
Q1 2014 14,020,133 12 May 2014 10-Q 15 May 2014 2014 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.